Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 6 (2009), Issue 4 (April)

1. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
   J Neurochem, 109(2): 623-30. [Abstract] [Full-text]
2. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.
   J Neurochem, 109(2): 303-15. [Abstract] [Full-text]
3. Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.
   J Neurochem, 109(2): 502-12. [Abstract] [Full-text]
4. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.
   FASEB J, 23(4): 1146-52. [Abstract] [Full-text]
5. Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.
   J Neuropathol Exp Neurol, 68(4): 417-24. [Abstract] [Full-text]
6. Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorder.
   J Neuropathol Exp Neurol, 68(4): 432-9. [Abstract] [Full-text]
7. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.
   Am J Pathol, 174(4): 1241-51. [Abstract] [Full-text]
8. Identification of casein kinase-1 phosphorylation sites on TDP-43.
   Biochem Biophys Res Commun, 382(2): 405-9. [Abstract] [Full-text]
9. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
   Biochem Biophys Res Commun, 382(1): 149-52. [Abstract] [Full-text]
10. A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease.
    Biochem Biophys Res Commun, 382(1): 91-5. [Abstract] [Full-text]
11. Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1DeltaE9.
    Brain Res, 1266: 87-92. [Abstract] [Full-text]
12. The neural basis of visuospatial perception in Alzheimer's disease and healthy elderly comparison subjects: an fMRI study.
    Psychiatry Res, 172(2): 109-16. [Abstract] [Full-text]
13. A comparison of neurocognitive impairment in younger and older adults with major depression.
    Psychol Med, 39(5): 725-33. [Abstract] [Full-text]
14. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.
    J Clin Endocrinol Metab, 94(4): 1223-8. [Abstract] [Full-text]
15. Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease.
    Clin Neurophysiol, 120(4): 709-18. [Abstract] [Full-text]
16. Genetic control of human brain transcript expression in Alzheimer disease.
    Am J Hum Genet, 84(4): 445-58. [Abstract] [Full-text]
17. The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease.
    Brain Cogn, 70(1): 171-9. [Abstract] [Full-text]
18. Approximate quantification in young, healthy older adults', and Alzheimer patients.
    Brain Cogn, 70(1): 53-61. [Abstract] [Full-text]
19. Problems inhibiting attentional capture by irrelevant stimuli in patients with frontotemporal dementia.
    Brain Cogn, 70(1): 62-6. [Abstract] [Full-text]
20. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
    Arch Neurol, 66(4): 448-57. [Abstract] [Full-text]
21. Epilepsy and cognitive impairments in Alzheimer disease.
    Arch Neurol, 66(4): 435-40. [Abstract] [Full-text]
22. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder.
    Neurology, 72(15): 1296-300. [Abstract] [Full-text]
23. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus.
    JAMA, 301(15): 1565-72. [Abstract] [Full-text]
24. Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice.
    J Neurosci, 29(15): 4964-71. [Abstract] [Full-text]
25. Common features between diabetes mellitus and Alzheimer's disease.
    Cell Mol Life Sci, 66(8): 1321-5. [Abstract] [Full-text]
26. Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease.
    Anesth Analg, 108(5): 1627-30. [Abstract] [Full-text]
27. Twin pairs discordant for neuropathologically confirmed Lewy body dementia.
    J Neurol Neurosurg Psychiatry, 80(5): 562-5. [Abstract] [Full-text]
28. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    J Mol Biol, 387(3): 584-606. [Abstract] [Full-text]
29. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
    Neuroimage, 46(2): 394-410. [Abstract] [Full-text]
30. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.
    Nat Rev Neurosci, 10(5): 333-44. [Abstract] [Full-text]
31. Higher level gait disorders in subcortical chronic vascular encephalopathy: a single photon emission computed tomography study.
    Age Ageing, 38(3): 302-7. [Abstract] [Full-text]
32. The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS).
    Age Ageing, 38(3): 319-25; discussion 251. [Abstract] [Full-text]
33. Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.
    Clin Pharmacol Ther, 85(5): 506-12. [Abstract] [Full-text]
34. The number of octapeptide repeat affects the expression and conversion of prion protein.
    Biochem Biophys Res Commun, 382(4): 715-9. [Abstract] [Full-text]
35. The impact of social amplification and attenuation of risk and the public reaction to mad cow disease in Canada.
    Risk Anal, 29(5): 714-28. [Abstract] [Full-text]
36. Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases.
    J Neurosci, 29(16): 5153-62. [Abstract] [Full-text]
37. The utility of a brief memory screen in the diagnosis of mild memory impairment in the elderly: preliminary study.
    Am J Geriatr Psychiatry, 17(5): 437-40. [Abstract] [Full-text]
38. Capacity to make treatment decisions in Chinese older persons with very mild dementia and mild Alzheimer disease.
    Am J Geriatr Psychiatry, 17(5): 428-36. [Abstract] [Full-text]
39. Differential FDDNP PET patterns in nondemented middle-aged and older adults.
    Am J Geriatr Psychiatry, 17(5): 397-406. [Abstract] [Full-text]
40. Androgens and Alzheimer's disease.
    Curr Opin Endocrinol Diabetes Obes, 16(3): 254-9. [Abstract] [Full-text]
41. Diagnosing Alzheimer's dementia in Down syndrome: problems and possible solutions.
    Res Dev Disabil, 30(5): 827-38. [Abstract] [Full-text]
42. Family oversight and the quality of nursing home care for residents with advanced dementia.
    Med Care, 47(5): 568-74. [Abstract] [Full-text]
43. Rescue of Abeta(1-42)-induced memory impairment in day-old chick by facilitation of astrocytic oxidative metabolism: implications for Alzheimer's disease.
    J Neurochem, 109: 230-6. [Abstract] [Full-text]
44. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    J Neurochem, 109: 153-9. [Abstract] [Full-text]
45. Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease.
    Am J Pathol, 174(5): 1602-8. [Abstract] [Full-text]
46. Impairment of long-term depression induced by chronic brain inflammation in rats.
    Biochem Biophys Res Commun, 383(1): 93-7. [Abstract] [Full-text]
47. Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease.
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 16(3): 357-76. [Abstract] [Full-text]
48. Predicting neuropsychological test performance on the basis of temporal orientation.
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 16(3): 330-7. [Abstract] [Full-text]
49. Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.
    J Biol Chem, 284(18): 11845-53. [Abstract] [Full-text]
50. Novel role of RanBP9 in BACE1 processing of amyloid precursor protein and amyloid beta peptide generation.
    J Biol Chem, 284(18): 11863-72. [Abstract] [Full-text]
51. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
    J Biol Chem, 284(18): 12384-98. [Abstract] [Full-text]
52. Face-name repetition priming in semantic dementia: a case report.
    Brain Cogn, 70(2): 231-7. [Abstract] [Full-text]
53. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.
    J Magn Reson Imaging, 29(5): 1021-6. [Abstract] [Full-text]
54. Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation.
    J Magn Reson Imaging, 29(5): 1008-12. [Abstract] [Full-text]
55. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.
    J Magn Reson Imaging, 29(5): 997-1007. [Abstract] [Full-text]
56. Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin.
    Neurobiol Aging, 30(6): 847-63. [Abstract] [Full-text]
57. Specificity of inhibitory deficits in normal aging and Alzheimer's disease.
    Neurobiol Aging, 30(6): 875-89. [Abstract] [Full-text]
58. Hippocampal volume is an independent predictor of cognitive performance in CADASIL.
    Neurobiol Aging, 30(6): 890-7. [Abstract] [Full-text]
59. Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.
    J Biol Chem, 284(18): 12447-58. [Abstract] [Full-text]

© 2004-2012 Dementia Research Today. All Rights Reserved.